Logo image of RDI

READING INTERNATIONAL INC-A (RDI) Stock Fundamental Analysis

NASDAQ:RDI - Nasdaq - US7554081015 - Common Stock - Currency: USD

1.33  -0.01 (-0.75%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to RDI. RDI was compared to 72 industry peers in the Entertainment industry. RDI may be in some trouble as it scores bad on both profitability and health. RDI does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

RDI had negative earnings in the past year.
RDI had a negative operating cash flow in the past year.
RDI had negative earnings in 4 of the past 5 years.
RDI had a negative operating cash flow in each of the past 5 years.
RDI Yearly Net Income VS EBIT VS OCF VS FCFRDI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M -40M -60M

1.2 Ratios

The Return On Assets of RDI (-7.49%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -7.49%
ROE N/A
ROIC N/A
ROA(3y)-6.47%
ROA(5y)-4.84%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
RDI Yearly ROA, ROE, ROICRDI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 400 600 800

1.3 Margins

Looking at the Gross Margin, with a value of 10.41%, RDI is doing worse than 81.94% of the companies in the same industry.
RDI's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for RDI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 10.41%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y33.38%
GM growth 5Y-12.85%
RDI Yearly Profit, Operating, Gross MarginsRDI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60 -80

0

2. Health

2.1 Basic Checks

RDI does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for RDI has been increased compared to 1 year ago.
Compared to 5 years ago, RDI has more shares outstanding
Compared to 1 year ago, RDI has a worse debt to assets ratio.
RDI Yearly Shares OutstandingRDI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
RDI Yearly Total Debt VS Total AssetsRDI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

RDI has an Altman-Z score of -0.22. This is a bad value and indicates that RDI is not financially healthy and even has some risk of bankruptcy.
RDI's Altman-Z score of -0.22 is on the low side compared to the rest of the industry. RDI is outperformed by 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -0.22
ROIC/WACCN/A
WACC8.57%
RDI Yearly LT Debt VS Equity VS FCFRDI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 0.35 indicates that RDI may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.35, RDI is doing worse than 81.94% of the companies in the same industry.
A Quick Ratio of 0.34 indicates that RDI may have some problems paying its short term obligations.
RDI's Quick ratio of 0.34 is on the low side compared to the rest of the industry. RDI is outperformed by 81.94% of its industry peers.
Industry RankSector Rank
Current Ratio 0.35
Quick Ratio 0.34
RDI Yearly Current Assets VS Current LiabilitesRDI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

3

3. Growth

3.1 Past

RDI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -14.76%.
RDI shows a decrease in Revenue. In the last year, the revenue decreased by -5.52%.
RDI shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -5.33% yearly.
EPS 1Y (TTM)-14.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%53.37%
Revenue 1Y (TTM)-5.52%
Revenue growth 3Y14.81%
Revenue growth 5Y-5.33%
Sales Q2Q%29.25%

3.2 Future

RDI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 33.49% yearly.
RDI is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.98% yearly.
EPS Next Y60.48%
EPS Next 2Y33.49%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year11.61%
Revenue Next 2Y8.97%
Revenue Next 3Y7.98%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
RDI Yearly Revenue VS EstimatesRDI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
RDI Yearly EPS VS EstimatesRDI Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 1 -1 -2 -3

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for RDI. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for RDI. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RDI Price Earnings VS Forward Price EarningsRDI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as RDI.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 122.76
RDI Per share dataRDI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

A more expensive valuation may be justified as RDI's earnings are expected to grow with 33.49% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y33.49%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for RDI!.
Industry RankSector Rank
Dividend Yield N/A

READING INTERNATIONAL INC-A

NASDAQ:RDI (5/9/2025, 8:18:55 PM)

1.33

-0.01 (-0.75%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)03-31 2025-03-31/amc
Earnings (Next)05-19 2025-05-19/bmo
Inst Owners48.5%
Inst Owner Change-1.36%
Ins Owners7.96%
Ins Owner Change1.44%
Market Cap29.63M
Analysts80
Price Target2.55 (91.73%)
Short Float %0.65%
Short Ratio2.42
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-38.79%
Min EPS beat(2)-114.64%
Max EPS beat(2)37.06%
EPS beat(4)1
Avg EPS beat(4)-54.76%
Min EPS beat(4)-128.48%
Max EPS beat(4)37.06%
EPS beat(8)1
Avg EPS beat(8)-427.38%
EPS beat(12)2
Avg EPS beat(12)-302.04%
EPS beat(16)4
Avg EPS beat(16)-234.3%
Revenue beat(2)1
Avg Revenue beat(2)0.65%
Min Revenue beat(2)-8.14%
Max Revenue beat(2)9.43%
Revenue beat(4)2
Avg Revenue beat(4)-4.11%
Min Revenue beat(4)-19.13%
Max Revenue beat(4)9.43%
Revenue beat(8)2
Avg Revenue beat(8)-6.54%
Revenue beat(12)3
Avg Revenue beat(12)-4.91%
Revenue beat(16)5
Avg Revenue beat(16)-2.37%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-4.64%
EPS NY rev (1m)15.92%
EPS NY rev (3m)15.92%
Revenue NQ rev (1m)-10.35%
Revenue NQ rev (3m)-19.81%
Revenue NY rev (1m)-1.99%
Revenue NY rev (3m)-5.65%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.14
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 122.76
EPS(TTM)-1.58
EYN/A
EPS(NY)-0.62
Fwd EYN/A
FCF(TTM)-0.42
FCFYN/A
OCF(TTM)-0.17
OCFYN/A
SpS9.45
BVpS-0.2
TBVpS-1.34
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.49%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 10.41%
FCFM N/A
ROA(3y)-6.47%
ROA(5y)-4.84%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y33.38%
GM growth 5Y-12.85%
F-Score5
Asset Turnover0.45
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 74.3
Cap/Depr 35.01%
Cap/Sales 2.63%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.35
Quick Ratio 0.34
Altman-Z -0.22
F-Score5
WACC8.57%
ROIC/WACCN/A
Cap/Depr(3y)34.68%
Cap/Depr(5y)51%
Cap/Sales(3y)3.09%
Cap/Sales(5y)8.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-14.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%53.37%
EPS Next Y60.48%
EPS Next 2Y33.49%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-5.52%
Revenue growth 3Y14.81%
Revenue growth 5Y-5.33%
Sales Q2Q%29.25%
Revenue Next Year11.61%
Revenue Next 2Y8.97%
Revenue Next 3Y7.98%
Revenue Next 5YN/A
EBIT growth 1Y-16.4%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year221.58%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y34.04%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y60.63%
OCF growth 3YN/A
OCF growth 5YN/A